VEGF has also been shown to increase the invasiveness of colorectal cancer cells or myeloma cells [15,16], and VEGFR1-blocking antibody was reported to inhibit the VEGF-induced invasiveness of these cells [15,16]. Here, FLT1 is linked to plasma cell myeloma.